Evidence map›Paper›PMID 26173998›Full record

ArticleProtein science : a publication of the Protein Society2015

Hypothetical protein CT398 (CdsZ) interacts with σ(54) (RpoN)-holoenzyme and the type III secretion export apparatus in Chlamydia trachomatis.

Michael L Barta, Kevin P Battaile, Scott Lovell, P Scott Hefty

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Type III Secretion inMicrobiology and molecular biology reviews : MMBR · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Crystal structure of the MSMEG_4306 gene product from Mycobacterium smegmatis.Acta crystallographica. Section F, Structural biology communications · 2018
    Article
  10. The Loss of Expression of a Single Type 3 Effector (CT622) Strongly ReducesFrontiers in cellular and infection microbiology · 2018
    Article
  11. Regulation ofEcoSal Plus · 2017
    Review
  12. Future science OA · 2017
    Article
  13. Chlamydia cell biology and pathogenesis.Nature reviews. Microbiology · 2016
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michael L BartaDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045.
Kevin P BattaileIMCA-CAT, Hauptman-Woodward Medical Research Institute, Argonne, Illinois.
Scott LovellProtein Structure Laboratory, Del Shankel Structural Biology Center, University of Kansas, Lawrence, KS, 66045.
P Scott HeftyDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045.
University of Kansas · USHauptman-Woodward Medical Research Institute · US

Funding

Protein Structure Laboratory P30GM110761 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2014 to 2018
$5.6M
Protein Structure and FunctionP20GM103420 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2012 to 2012
$2.0M
Regulation of Virulence Gene Expression in ChlamydiaR01AI079083 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI HEFTY, P SCOTT · 2010 to 2014
$1.8M
Development and Validation of Conditional Gene Expression Systems in ChlamydiaR21AI103711 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI HEFTY, P SCOTT · 2013 to 2014
$403k
NIAID NIH HHS AI079083NIAID NIH HHS R01 AI079083NIAID NIH HHS R21 AI103711NIGMS NIH HHS GM103420NIGMS NIH HHS P20 GM103420NIGMS NIH HHS P30 GM110761
6 · The paper itself

Abstract

A significant challenge to bacteriology is the relatively large proportion of proteins that lack sufficient sequence similarity to support functional annotation (i.e. hypothetical proteins). The aim of this study was to apply protein structural homology to gain insights into a candidate protein of unknown function (CT398) within the medically important, obligate intracellular bacterium Chlamydia trachomatis. C. trachomatis is a major human pathogen responsible for numerous infections throughout the world that can lead to blindness and infertility. A 2.12 Å crystal structure of hypothetical protein CT398 was determined that was comprised of N-terminal coiled-coil and C-terminal Zn-ribbon domains. The structure of CT398 displayed a high degree of structural similarity to FlgZ (Flagellar-associated zinc-ribbon domain protein) from Helicobacter pylori. This observation directed analyses of candidate protein partners of CT398, revealing interactions with two paralogous type III secretion system (T3SS) ATPase-regulators (CdsL and FliH) and the alternative sigma factor RpoN (σ(54) ). Furthermore, genetic introduction of a conditional expression, affinity-tagged construct into C. trachomatis enabled the purification of a CT398-RpoN-holoenzyme complex, suggesting a potential role for CT398 in modulating transcriptional activity during infection. The interactions reported here, in tandem with previous FlgZ studies in H. pylori, indicate that CT398 functions as a regulator of several key areas of chlamydial biology throughout the developmental cycle. Accordingly, we propose that CT398 be named CdsZ (Contact-dependent secretion-associated zinc-ribbon domain protein).

Indexed as

Models, BiologicalAmino Acid SequenceBacterial ProteinsChlamydia trachomatisComputer SimulationDNA-Directed RNA PolymerasesHoloenzymesModels, MolecularRNA Polymerase Sigma 54Sequence AlignmentSigma FactorBacterial ProteinsDNA-Directed RNA PolymerasesHoloenzymesRNA Polymerase Sigma 54Sigma FactorChlamydiacoiled-coilstructural proteomicstype III secretion systemZn-ribbon

Identifiers

PMID26173998
PMCPMC4594661
OpenAlexW2120879140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.